UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in RGNX — REGENXBIO Inc.
CIK 861177
NEW YORK, NY
Position in RGNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,366
+$6,120 QoQ
Shares Held
1,700
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#130
of 163 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. RGNX ranks #154 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in RGNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,366 | 1,700 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,246 | 1,700 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,417 | 654 | Shares | Defined | 2026-02-13 | |
| 2024-12-31 | $557,973 | 72,183 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $693,156 | 66,078 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $830,206 | 70,958 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $812,119 | 38,544 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $691,863 | 38,544 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $634,432 | 38,544 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $505,883 | 25,307 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $478,552 | 25,307 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $782,413 | 34,498 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $964,561 | 36,495 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $901,424 | 36,495 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,254,247 | 37,790 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,235,730 | 37,790 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,584,154 | 37,790 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,532,358 | 39,443 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,256,303 | 36,831 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,219,729 | 26,890 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $740,010 | 26,890 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $990,356 | 26,890 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $724,177 | 22,365 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||